SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-09-235600
Filing Date
2009-11-16
Accepted
2009-11-16 15:17:12
Documents
5
Period of Report
2009-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 270135
2 DEVELOPMENT AND LICENSE AGREEMENT dex101.htm EX-10.1 307039
3 CERTIFICATION OF CEO PURSUANT TO RULES 13A-15(F) dex311.htm EX-31.1 9061
4 CERTIFICATION OF CFO PURSUANT TO RULES 13A-15(F) dex312.htm EX-31.2 9038
5 CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. SECTION 1350 dex32.htm EX-32 5852
  Complete submission text file 0001193125-09-235600.txt   602648
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
AP PHARMA INC /DE/ (Filer) CIK: 0000818033 (see all company filings)

IRS No.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 091186268
SIC: 2834 Pharmaceutical Preparations